Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
PaperCitations, authors & open-access status
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 563 citations, 2017 year and closed oa status.
563
Citations
2017
Year
closed
OA Status